Therapeutic time window for the neuroprotective effects of NGF when administered after focal cerebral ischemia

Neurol Sci. 2011 Jun;32(3):433-41. doi: 10.1007/s10072-011-0512-9. Epub 2011 Mar 16.

Abstract

In the present study, we evaluated the neuroprotection time window for nerve growth factor (NGF) after ischemia/reperfusion brain injury in rabbits as related to this anti-apoptosis mechanism. Male New Zealand rabbits were subjected to 2 h of middle cerebral artery occlusion (MCAO), followed by 70 h of reperfusion. NGF was administered after injury to evaluate the time window. Neurological deficits, infarct volume, neural cell apoptosis and expressions of caspase-3 and Bcl-2 were measured. Compared to saline-treated control, NGF treatment at 2, 3 and 5 h after MCAO significantly reduced infarct volume, neural cell apoptosis and expression of caspase-3 (P < 0.01), up-regulated the expression of Bcl-2 and improved functional recovery (P < 0.01). However, treatment at latter time points did not produce significant neuroprotection. Neuroprotection treatment with NGF provides an extended time window of up to 5 h after ischemia/reperfusion brain injury, in part by attenuating the apoptosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain Ischemia / drug therapy*
  • Brain Ischemia / metabolism*
  • Brain Ischemia / pathology
  • Disease Models, Animal
  • Drug Administration Schedule
  • Injections, Intraventricular
  • Male
  • Nerve Growth Factor / administration & dosage*
  • Nerve Growth Factor / physiology
  • Neuroprotective Agents / administration & dosage*
  • Neuroprotective Agents / pharmacology
  • Rabbits
  • Reperfusion Injury / drug therapy*
  • Reperfusion Injury / metabolism*
  • Reperfusion Injury / pathology
  • Time Factors

Substances

  • Neuroprotective Agents
  • Nerve Growth Factor